Skip to main content

Investment Strategies

Boosting Thailand’s investment of public funds in biotech will take educating political leaders, and rice farmers, too.

Written byThana Poopat
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00

Chief scientists, policy makers, and key stakeholders in science and technology development agree that biotechnology has the potential to transform every aspect of Thailand’s economic and social life for the better. But the promise of biotechnology cannot be realized, they argue, unless it is guided by a clear vision, a strong sense of purpose, and broad public appeal.

Most critical is the paltry level of government investment. Thailand’s public expenditures on research and development rank fifty-first among 53 countries surveyed by the World Competitive Yearbook in 2008. Total Thai expenditures on R&D are 0.24 percent of GDP, about a third of Malaysia’s levels and a tenth of Singapore’s.

“Thailand has been investing in biotechnology research as if we were a small-time player,” says Pongthep Akratanakul of the Center for Agricultural Biotechnology. “We’re one of the world’s agricultural powerhouses. There must be something seriously wrong about our self-perception or self-esteem.”

“It’s ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Published In

Related articles background image
The Scientist October Digest cover
October 2026

Antarctica’s Blood Falls Teems With Mysterious Microbial Life

Miles away from the closest ocean, marine microbes thrive in the red ice and mud around Blood Falls, offering clues to microbial adaptation and past climate events.

View this Issue
Evaluating Blood Biomarkers for Alzheimer’s Disease Staging

Evaluating Blood Biomarkers for Alzheimer’s Disease Staging

​Beckman Coulter
Find better biologics faster with Stunner and the AI Developability Workcell

Find better biologics faster with Stunner and the AI Developability Workcell

Unchained Labs
An image of microcentrifuge tubes arranged within colorful laboratory racks.

Choose clarity. Choose speed. Choose MyMass™

Refeyn
Characterizing LNP Heterogeneity With Super-Resolution Imaging

Characterizing LNP Heterogeneity With Super-Resolution Imaging

Oni

Products

Stellaromics Logo

Stellaromics Expands Pyxa Adoption as Instruments are Installed at Leading Research Institutions Across the U.S. and EuropeStellaromics, Inc., the leader in 3D

A monoclonal antibody surrounded by immune cells and red blood cells

CellRaft AIR: Find the Right Antibody-Producing Cells Faster

Cell Microsystems
Maxwell® Rapid ccfDNA Kit

Maxwell® Rapid ccfDNA Kit: Automated Purification of ccfDNA in Under 30 Minutes

Promega
Leica Biosystems, Tempus, and Paige logos side by side, marking the addition of Paige digital pathology AI tools to the Aperio AI Store.

Oncology Researchers Gain AI Cancer Tools in One Platform